Search Results - "Nan, Yingyu"

Co-culture of dendritic cells and cytokine-induced killer cells effectively suppresses liver cancer stem cell growth by inhibiting pathways in the immune system by Yang, Tao, Zhang, Wenjun, Wang, Li, Xiao, Chunyan, Wang, Li, Gong, Yi, Huang, Dehong, Guo, Bingling, Li, Qiying, Xiang, Ying, Nan, Yingyu

“…Application of dendritic cells (DC) for cancer immunotherapy involves tumor-associated immunogenic antigens for effective therapeutic strategies. The present…”
Get full text

Clinical characteristics and outcomes of newly diagnosed patients with HIV‐associated aggressive B‐cell NHL in China by Wang, Chaoyu, Liu, Jun, Lei, Haike, Li, Yu, Wu, Jian, Guo, Bingling, Hu, Renzhi, Liu, Tingting, Wu, Jing, Ding, Yao, Hu, Chongling, Liang, Shunsi, Xiao, Chunyan, Liang, Xiping, Huang, Dehong, Yang, Tao, Zhang, Wenjun, Yang, Zailin, Li, Jieping, Nan, Yingyu, Li, Qiying, Xiang, Ying, Li, Zhenhua, Wu, Yongzhong, Liu, Yao

“…Little is known about the incidence, clinical characteristics and prognostic factors in HIV associated lymphoma as these are less common than HIV‐negative…”
Get full text

miR-744-5p Inhibits Multiple Myeloma Proliferation, Epithelial Mesenchymal Transformation and Glycolysis by Targeting SOX12/Wnt/β-Catenin Signaling by Guo, Bingling, Xiao, Chunyan, Liu, Yumin, Zhang, Ning, Bai, Hao, Yang, Tao, Xiang, Ying, Nan, Yingyu, Li, Qiying, Zhang, Wenjun, Huang, Dehong

“…This study investigated the function and molecular mechanisms of miR-744-5p in multiple myeloma (MM). miR-744-5p and SRY-related high-mobility-group box 12…”
Get full text

Long intergenic noncoding RNA-p21 inhibits apoptosis by decreasing PUMA expression in non-small cell lung cancer by Yang, Tao, Zhang, Wenjun, Wang, Li, Xiao, Chunyan, Guo, Bingling, Gong, Yi, Liang, Xiping, Huang, Dehong, Li, Qiying, Nan, Yingyu, Xiang, Ying, Shao, Jianghe

“…Objective Long noncoding RNAs (lncRNAs) are important mediators in tumor progression. Long intergenic noncoding RNA-p21 (lincRNA-p21) participates in multiple…”
Get full text

PB2310: CHIDAMIDE WITH AZACITIDINE AND CHOP TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED PERIPHERAL T‐CELL LYMPHOMA:INTERIM ANALYSIS OF A PROSPECTIVE,SINGLE CENTER,SINGLE‐ARM, PHASE 2 TRIAL by Xiao, Chunyan, Ding, Yao, Zeng, Chensi, Nan, Yingyu, Liu, Yao

Get full text

Antibody responses to SARS‐CoV‐2 Omicron infection in patients with hematological malignancies: A multicenter, prospective cohort study by Li, Jun, Liu, Yi, Wei, Xia, Liu, Zhanshu, Yang, Zailiang, Liu, Ling, Zhou, Meiyu, Xu, Guofa, Chen, Lanting, Ding, Yao, Lei, Haike, Yang, Zailin, Chen, Shuang, Zhang, Xiaomei, Tang, Yifeng, Fu, Huihui, He, Sanxiu, Guo, Bingling, Liang, Xiping, Zhang, Lingqian, Zhang, Wenjun, Wu, Jing, Wang, Chaoyu, Hu, Chongling, Hu, Renzhi, Luo, Xin, Quan, Xi, Zeng, Chensi, Liang, Shunsi, Liu, Tingting, Lv, Jing, Luo, Qin, Qi, Qin, Xu, Luxiang, Xiong, Yan, Liu, Jueyin, Huang, Dehong, Xiao, Chunyan, Liu, Jun, Yang, Tao, Xiang, Ying, Li, Qiying, Nan, Yingyu, Li, Jieping, Zhang, Yong, Wu, Yongzhong, Liu, Yao

“…Little is known about antibody responses to natural Omicron infection and the risk factors for poor responders in patients with hematological malignancies…”
Get full text

Risk factors for COVID-19 pneumonia in patients with hematological malignancies: a multi-center, prospective study in China by Li, Jun, Chen, Ran, Cao, Lin, Liu, Yi, Zhang, Yong, Wei, Xia, Liu, Zhanshu, Yang, Zailiang, Liu, Ling, Zhou, Meiyu, Xu, Guofa, Chen, Lanting, Ding, Yao, Lei, Haike, Liu, Lisheng, Yang, Zailin, Chen, Shuang, Zhang, Xiaomei, Tang, Yifeng, Fu, Huihui, He, Sanxiu, Xiao, Qing, Xie, Xiaoqing, Li, Qiying, Nan, Yingyu, Li, Jieping, Chen, Xiaoliang, Liu, Yao

“…We aimed to investigate risk factors for COVID-19 pneumonia in patients with hematological malignancies (HM) after Omicron infection.PurposeWe aimed to…”
Get full text

Long‐term efficacy and safety of programmed death‐1 (PD‐1) antibody alone in relapsed/refractory human immunodeficiency virus‐associated Hodgkin lymphoma by Wang, Chaoyu, Zhou, Fanlin, Zhang, Lingqian, Liu, Tingting, Nan, Yingyu, Liu, Yao

“…We report a young patient initially diagnosed with human immunodeficiency virus (HIV)‐associated Hodgkin lymphoma (HL), and received six cycles of ABVD…”
Get full text

PB2316: SAFETY AND EFFICACY OF AUTOLOGOUS HSCT IN NINE PATIENTS WITH AIDS‐RELATED NON‐HODGKIN LYMPHOMA by Liu, Jun, Zhou, Yixing, Liang, Shunsi, Zeng, Chensi, Huang, Dehong, Xiao, Chunyan, Yang, Tao, LI, Jieping, Nan, Yingyu, LI, Qiying, Xiang, Ying, Liu, Yao

Get full text

Role of Exosome in Microenvironment of Hematological Malignancies and Its Diagnostic and Therapeutic Potential by Nan, Yingyu, Yao, Xuan, Yang, Zhong

“…Exosome, a major component of extracellular vesicles, is an important media for intercellular communications under physiological conditions. In a variety of…”
Get full text

Chidamide with Azacitidine and CHOP Treatment Plus Autologous Transplantation,Followed By Maintenance with Chidamide for Patients with Newly Diagnosed Peripheral T-Cell Lymphoma: Interim Analysis of a Prospective,Single Center,Single-Arm, Phase 2 Trial by Xiao, Chunyan, Ding, Yao, Zeng, Chensi, Zhang, Lingqian, Guo, Bingling, Nan, Yingyu, Liu, Yao

“…Background: The standard first-line treatment for peripheral T-Cell Lymphoma (PTCL) is cyclophosphamide, doxorubicin, vincristine, and prednison (CHOP)，but the…”
Get full text

The Publication Trends and Hotspots of Multiple Myeloma Research from 2010 to 2019: A 10-Year Bibliometric Analysis by Zeng, Chensi, Xiao, Chunyan, Zhang, Lingqian, Yang, Tao, Xiang, Ying, Nan, Yingyu, Liu, Yao

Get full text

Chidamide with Azacitidine and CHOP Treatment Plus Autologous Transplantation, Followed By Maintenance with Chidamide for Patients with Newly Diagnosed Peripheral T-Cell Lymphoma (PTCL): Interim Analysis of a Prospective,Single Center, Single-Arm, Phase 2 Trial by Xiao, Chunyan, Ding, Yao, Zeng, Chensi, Zhang, Lingqian, Guo, Bingling, Nan, Yingyu, Liu, Yao

Get full text

Zanubrutinib Combined with R-CHOP As the First-Line Treatment for Newly Diagnosed Diffuse Large B-Cell Lymphoma with Extranodal Involvement: A Prospective Phase II Trial in China by Hu, Chongling, Yang, Tao, Jun, Li, Zhang, Wenjun, Guo, Bingling, Wang, Chaoyu, Liu, Jun, Xiao, Chunyan, Huang, Dehong, Yang, Zailin, Liu, Tingting, Li, Jieping, Nan, Yingyu, Liu, Yao

“…BACKGROUND About one-third of Diffuse large B-cell lymphoma (DLBCL) arises primarily from extranodal sites, patients with extranodal involvement indicates poor…”
Get full text

Safety and Efficacy of Autologous HSCT in Nine Patients with AIDS-Related Non-Hodgkin Lymphoma by Liu, Jun, Zhou, Yixing, Liang, Shunsi, Zeng, Chensi, Zhang, Lingqian, Huang, Dehong, Xiao, Chunyan, Yang, Tao, Li, Jieping, Nan, Yingyu, Li, Qiying, Xiang, Ying, Liu, Yao

“…Background：In recent years, with the application of HIV combined with resistance retroviral therapy, the number of AIDS-NHL patients has gradually increased,…”
Get full text

Selinexor in Combination with R-EPOCH for Patients with Previously Untreated HIV-Associated Diffuse Large B Cell Lymphoma(DLBCL) by Wang, Chaoyu, Zhou, Yixing, Zeng, Chensi, Guo, Bingling, Yang, Tao, Liu, Jun, Huang, Dehong, Xiao, Chunyan, Li, Jieping, Nan, Yingyu, Li, Qiying, Liu, Yao

“…Introduction : The incidence of HIV-positive lymphoma remains significantly higher than HIV-negative patients in the era of combined antiretroviral…”
Get full text

Risk Factors for Omicron Pneumonia in Patients with Hematological Malignancies: A Multicenter Study in China by Jun, Li, Liu, Yi, Wei, Xia, Liu, Zhanshu, Yang, Zailiang, Liu, Ling, Zhou, Meiyu, Xu, Guofa, Chen, Lanting, Ding, Yao, Lei, Haike, Li, Qiying, Nan, Yingyu, Li, Jieping, Zhang, Yong, Wu, Yongzhong, Liu, Yao

“…BACKGROUND Although Omicron's hospitalization rate and mortality rate decreased significantly in the immunocompetent population (Wang B, et al. J Infect 2023;…”
Get full text

Autologous Hematopoietic Stem Cell Transplantation Combined with High-Dose Chemotherapy As First-Line Treatment for HIV-Associated Lymphoma: A Retrospective Analysis by Guo, Bingling, Hu, Renzhi, Liang, Xiping, Yang, Zailin, Yang, Tao, Wang, Chaoyu, Hu, Chongling, Zhang, Wenjun, Xiao, Chunyan, Liu, Jun, Huang, Dehong, Liu, Tingting, Nan, Yingyu, Li, Jieping, Liu, Yao

“…BACKRGOUND At present, lymphoma is one of the three most common malignant tumors in AIDS patients. With the popularization of cART treatment, the incidence of…”
Get full text

Increased SARS-CoV-2 reinfection frequency, attenuated severity, and risk factor analysis in patients with hematological malignancies by Li, Jun, Zhang, Yong, Liu, Zhanshu, Yang, Zailiang, Liu, Ling, Xu, Guofa, Yang, Zailin, Xiong, Yan, Liu, Jueyin, Zhang, Xiaomei, Xiang, Ying, Li, Qiying, Nan, Yingyu, Li, Jieping, Wu, Yongzhong, Liu, Yao

“…•HMs exhibit a notably higher rate of SARS-CoV-2 reinfection compared to the general population.•SARS-CoV-2 reinfection in HMs is less severe, with lower rates…”
Get full text

Efficacy and Safety of Polatuzumab Vedotin in Combination with Rituximab Plus Bendamustine in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Single Center Analysis of Pola Compassionate Use Program (CUP) in China by Yang, Tao, Li, Jun, Zhang, Lingqian, Hu, Renzhi, Wu, Jing, Ding, Yao, Liang, Xiping, Quan, Xi, Hu, Chongling, Zhang, Wenjun, Guo, Bingling, Wang, Chaoyu, Li, Qiying, Li, Jieping, Nan, Yingyu, Xiang, Ying, Liu, Yao

Get full text